AV
Advent Venture Partners
Venture CapitalActiveAdvent Venture Partners is one of EuropeвАЩs growth and venture capital investors in market-leading tech and life sciences businesses.
London, United KingdomFounded 1999
85
Investments
10
Exits
$1.2B
AUM
11.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Advent Venture Partners.
Investment Thesis & Strategy
Advent Venture Partners invests in market-leading technology and life sciences businesses across various stages in Europe. They focus on growth and venture capital investments.
Investment Activity
Deals per year over the last 14 years
2
20080
20090
20100
20110
20120
20133
20140
20152
20162
20172
20180
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 85 companies
B
Baseimmune
Biotech · Seed, 2021
Q
Q-State Biosciences
Biotech · Series A, 2018
A
Aptus Clinical
Biotech · Series A, 2018
I
Innovate UK
Other · Growth, 2017
P
PhoreMost
Biotech · Series A, 2017
U
Ultrahaptics
Robotics · Series B, 2016
C
Congenica
Biotech · Series A, 2016
C
Cell Medica
Biotech · Series A, 2014
M
MedCity
Healthcare · Growth, 2014
E
EviCore Healthcare
Healthcare · Growth, 2014
X
Xention
Biotech · Series A, 2008
F
F-star Therapeutics
Biotech · Series A, 2008
Notable Exits
CompanyTypeYearValue / Acquirer
RavelinAcquisition2023—
AvectoAcquisition2019—
ZynstraAcquisition2018—
FairsailAcquisition2017—
SpiderCloud WirelessAcquisition2017—
MimecastIPO2015$200M
RedEyeAcquisition2014—
QlikTechIPO2010$1.2B
Last.fmAcquisition2007$280M
SS&C TechnologiesIPO2007—
Frequently Asked Questions
Advent Venture Partners focuses on Series A, Series B, Series C+ stage investments.